Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Medicines Law & Policy
19 POSTS
0 COMMENTS
The European Commission says Covid-19 vaccines should be global public goods, but do their...
Medicines Law & Policy
-
January 28, 2021
Wrapping up 2020 with some noteworthy medicines, law and policy events
Medicines Law & Policy
-
December 29, 2020
COVID-19 Technology Access Pool (C-TAP): A Promising Human Rights Approach
Medicines Law & Policy
-
June 18, 2020
Medicines Law & Policy welcomes WHO’s Solidarity Call to Action to realise equitable global...
Medicines Law & Policy
-
May 29, 2020
Watch the webinar on the WHO Covid-19 Technology Pool
Medicines Law & Policy
-
May 15, 2020
Drug Price Transparency Calls Move from South Africa to World Health Assembly
Medicines Law & Policy
-
May 18, 2019
WHO Fair Pricing Forum: Watching for Drug Industry Accountability
Medicines Law & Policy
-
April 11, 2019
Medicines Law & Policy expert wins Prescrire Prize for “major reference work” on IP...
Medicines Law & Policy
-
October 5, 2017
“The diseases were in the South and the drugs were in the North”: Ellen...
Medicines Law & Policy
-
July 7, 2017
1
2
Page 2 of 2
This work is licensed under Creative Commons.